Ellsworth Advisors LLC Has $609,000 Stock Holdings in Transcat, Inc. (NASDAQ:TRNS)

Ellsworth Advisors LLC raised its holdings in Transcat, Inc. (NASDAQ:TRNS) by 4.4% in the 3rd quarter, according to the company in its most recent filing with the SEC. The firm owned 5,041 shares of the scientific and technical instruments company’s stock after acquiring an additional 213 shares during the quarter. Ellsworth Advisors LLC’s holdings in Transcat were worth $609,000 as of its most recent SEC filing.

Other large investors have also recently modified their holdings of the company. Wasatch Advisors LP increased its holdings in Transcat by 7.9% in the first quarter. Wasatch Advisors LP now owns 756,220 shares of the scientific and technical instruments company’s stock valued at $84,266,000 after purchasing an additional 55,121 shares during the period. Quadrature Capital Ltd acquired a new stake in shares of Transcat in the first quarter valued at about $619,000. Calamos Advisors LLC raised its position in shares of Transcat by 76.0% during the second quarter. Calamos Advisors LLC now owns 15,441 shares of the scientific and technical instruments company’s stock worth $1,848,000 after acquiring an additional 6,667 shares during the last quarter. First Horizon Advisors Inc. boosted its holdings in Transcat by 26.4% in the second quarter. First Horizon Advisors Inc. now owns 599 shares of the scientific and technical instruments company’s stock valued at $72,000 after acquiring an additional 125 shares during the last quarter. Finally, Quest Partners LLC bought a new position in Transcat during the 2nd quarter worth approximately $109,000. Institutional investors own 98.34% of the company’s stock.

Analyst Ratings Changes

A number of research firms have recently commented on TRNS. HC Wainwright reaffirmed a “buy” rating and issued a $156.00 price objective on shares of Transcat in a research note on Tuesday, July 30th. Craig Hallum cut their price target on shares of Transcat from $150.00 to $138.00 and set a “buy” rating on the stock in a research report on Wednesday, July 31st. Two investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $151.33.

Transcat Stock Performance

Transcat stock opened at $132.45 on Friday. The stock’s 50 day moving average price is $123.11 and its two-hundred day moving average price is $121.58. The stock has a market capitalization of $1.21 billion, a price-to-earnings ratio of 78.37 and a beta of 0.67. Transcat, Inc. has a 52-week low of $84.45 and a 52-week high of $147.12.

Transcat (NASDAQ:TRNS) last posted its quarterly earnings results on Monday, July 29th. The scientific and technical instruments company reported $0.48 EPS for the quarter, topping analysts’ consensus estimates of $0.28 by $0.20. Transcat had a net margin of 5.69% and a return on equity of 8.48%. The business had revenue of $66.70 million during the quarter, compared to analysts’ expectations of $69.35 million. During the same period last year, the company posted $0.38 earnings per share. The business’s quarterly revenue was up 10.1% on a year-over-year basis. On average, equities research analysts forecast that Transcat, Inc. will post 2.06 EPS for the current year.

About Transcat

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.